AT&T teams with eCardio Diagnostics for mobile cardiac care
07 Oct 2010
eCardio Diagnostics, a developer of arrhythmia monitoring solutions, has joined forces with AT&T to provide mobile technology-based care for heart patients. Under the partnership, AT&T is providing eCardio with machine-to-machine (M2M) wireless data and mobile connectivity for near real-time, remote monitoring.
eCardio's monitoring solution on cardiac devices allows heart patients to recover at home rather than spend additional time in the hospital. eCardio has implemented the solution on nearly 10,000 cardiac devices – and plans to deploy it across thousands more over the coming year.
AT&T's wireless connectivity for the monitoring solution allows doctors to get critical patient information in near real-time, as circumstances occur, shortening response times to heart issues. This improves clinical productivity, offering timely access to accurate patient information from any Internet-enabled computer.
This solution not only provides more appealing experience for the patient, it also helps hospitals, health insurance companies, pharmacies, drug retailers and research organizations lower their costs of treating arrhythmia patients.
eCardio offers an array of clinical services and devices designed to simplify and streamline the process of arrhythmia monitoring. This allows doctors to make more precise diagnoses and enhance the follow-up and management of their patients. eCardio has served thousands of patients suffering from heart rhythm disorders and provided physicians with leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy in the diagnoses of cardiac arrhythmias.
"We're focused on providing a total solution to physicians and patients," said Andrew Arroyo, vice president, information technology at eCardio. "AT&T is helping us implement innovative mobile technologies that are transforming the field of diagnostic medicine and advancing arrhythmia treatments. AT&T delivered the expertise and services we needed to create an end-to-end mobility solution that improves the patient experience and physician productivity."
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.